BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
240 results:

  • 1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
    Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
    Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
    Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mechanisms of action and resistance in histone methylation-targeted therapy.
    Yamagishi M; Kuze Y; Kobayashi S; Nakashima M; Morishima S; Kawamata T; Makiyama J; Suzuki K; Seki M; Abe K; Imamura K; Watanabe E; Tsuchiya K; Yasumatsu I; Takayama G; Hizukuri Y; Ito K; Taira Y; Nannya Y; Tojo A; Watanabe T; Tsutsumi S; Suzuki Y; Uchimaru K
    Nature; 2024 Mar; 627(8002):221-228. PubMed ID: 38383791
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes.
    Huang YH; Qiu YR; Zhang QL; Cai MC; Yu H; Zhang JM; Jiang L; Ji MM; Xu PP; Wang L; Cheng S; Zhao WL
    Cell Rep Med; 2024 Feb; 5(2):101416. PubMed ID: 38350451
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
    Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
    [No Abstract]    [Full Text] [Related]  

  • 6. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
    Messéant O; Drieux F; Sako N; Fataccioli V; Camus V; Robe C; Houot R; Tas P; Llamas-Gutierrez F; Lamaison C; Abraham J; Delage-Corre M; Benguerfi S; Bossard JB; Gaulard P; Lemonnier F
    Eur J Cancer; 2024 Jan; 197():113479. PubMed ID: 38128263
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.
    Kawaji-Kanayama Y; Tsukamoto T; Nakano M; Tokuda Y; Nagata H; Mizuhara K; Katsuragawa-Taminishi Y; Isa R; Fujino T; Matsumura-Kimoto Y; Mizutani S; Shimura Y; Taniwaki M; Tashiro K; Kuroda J
    Cancer Sci; 2024 Feb; 115(2):452-464. PubMed ID: 38050664
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
    Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
    Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of persisting DNMT3A, ASXL1, and tet2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission.
    Lai X; Xiao J; Wang T; Hou C; Chen J; Wu D; Xu Y
    Leuk Lymphoma; 2024 Mar; 65(3):363-371. PubMed ID: 37990829
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
    Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
    Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [TFH lymphoma and associated clonal hematopoiesis].
    Nann D; Fend F; Quintanilla-Martinez L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
    Veltmaat N; Zhong Y; de Jesus FM; Tan GW; Bult JAA; Terpstra MM; Mutsaers PGNJ; Stevens WBC; Mous R; Vermaat JSP; Chamuleau MED; Noordzij W; Verschuuren EAM; Kok K; Kluiver JL; Diepstra A; Plattel WJ; van den Berg A; Nijland M
    J Hematol Oncol; 2023 Sep; 16(1):104. PubMed ID: 37705050
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell lymphoma Patients.
    Chen C; Huang L; Chen Z; Ou Q; Liu S; Jiang X; Chen F; Wei X; Guo H; Shao Y; Zeng C; Li Y; Li W
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300042. PubMed ID: 37658484
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
    Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
    Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
    Jain AG; Ball S; Aguirre LE; Tobon KA; Chan O; Padron E; Kuykendall A; Komrokji R; Sallman D; Lancet JE; Sweet K
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e315-e322. PubMed ID: 37558530
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various lymphoma Subtypes.
    Kim JJ; Kim HM; Kim H; Kim SJ; Lee ST; Choi JR; Shin S; Hwang DY
    Cancer Res Treat; 2024 Jan; 56(1):314-323. PubMed ID: 37475138
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories.
    Borate U; Yang F; Press R; Ruppert AS; Jones D; Caruthers S; Zhao W; Vergilio JA; Pavlick DC; Juckett L; Norris B; Bucy T; Burd A; Stein EM; Patel P; Baer MR; Stock W; Schiller G; Blum W; Kovacsovics T; Litzow M; Foran J; Heerema NA; Rosenberg L; Marcus S; Yocum A; Stefanos M; Druker B; Byrd JC; Levine RL; Mims A
    Blood Adv; 2023 Oct; 7(20):6048-6054. PubMed ID: 37459200
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
    Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
    Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
    Fei F; Stehr H; Zehnder JL
    Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.